Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P83
Within normal range
Streak
2 yr
Consecutive growthStrong
Average
-973.60%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00% | +100.0% |
| 2024 | -22.80% | +99.4% |
| 2023 | -3867.81% | -123.6% |
| 2022 | -1730.05% | -322.1% |
| 2021 | -409.85% | +47.8% |
| 2020 | -784.68% | - |
| 2019 | 0.00% | - |